Human Papillomavirus
Human Papillomavirus
Monday, August 11, 2025 (12:00 PM - 1:00 PM) (CDT)
Description
This targeted webinar is designed for practicing physicians seeking up-to-date clinical guidance on Human Papillomavirus (HPV). The session will cover current evidence on HPV epidemiology, associated disease risks—including cervical, oropharyngeal, and other anogenital cancers—and best practices for prevention and patient counseling. Emphasis will be placed on integrating HPV vaccination and screening recommendations into routine clinical care.
Learning Objectives:
- Explain the latest clinical evidence on HPV transmission, pathogenesis, and associated disease burden.
- Apply current CDC and ACIP guidelines for HPV vaccination and cervical cancer screening in clinical practice
- Effectively counsel patients and caregivers on HPV-related risks and the benefits of vaccination and early detection.
Speaker: Dr. Ashlesha Kaushik, MD, FAAP
- Medical Director, UnityPoint Clinic Pediatric Infectious Diseases, Chief Medical Information Officer (CMIO), UnityPoint Health, Sioux City, IA
- Director, Antimicrobial Stewardship Program and Chair, Pharmacotherapeutics and Nutrition (PT&N)
- UnityPoint Health at St. Luke's,
- Clinical Associate Professor, Department of Pediatrics, University of Iowa Carver College of Medicine,
- Iowa American Academy of Pediatrics Vice President
- American Academy of Pediatrics National Spokesperson, IA Chapter Immunization Representative, IA Immunization coalition Scientific Advisory Chair,
- CDC Project Firstline/AAP IPC National ECHO Faculty
- CDC Project Firstline/American Academy of Pediatrics Infection Prevention and Control Ambassador for Iowa and Invited Visiting Faculty at Harvard
Continuing Education
Des Moines University Medicine and Health Sciences is the accredited provider and has approved this activity for AMA PRA Category 1 Credit™, American Osteopathic Association credit, and continuing education contact hours. The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. No ineligible company provided financial support for this continuing education activity. If you have questions regarding continuing education credit, please email cme@dmu.edu.
Sponsored by the American Academy of Pediatrics
11